| Q2 2024 |
3 |
$117M |
+$7.27M |
$0 |
+$7.27M |
APO, COOP, OMF
|
13F-HR |
8/14/2024, 10:45 AM |
| Q1 2024 |
3 |
$107M |
+$1.28M |
-$90.8M |
-$89.5M |
APO, COOP, OMF
|
13F-HR |
5/15/2024, 09:44 AM |
| Q4 2023 |
4 |
$166M |
+$20.9M |
-$944K |
+$20M |
APO, COOP, OMF, CUROQ
|
13F-HR |
2/14/2024, 08:22 AM |
| Q3 2023 |
3 |
$136M |
$0 |
-$27M |
-$27M |
APO, COOP, CUROQ
|
13F-HR |
11/14/2023, 09:42 AM |
| Q2 2023 |
3 |
$146M |
$0 |
-$7.68M |
-$7.68M |
APO, COOP, CUROQ
|
13F-HR |
8/14/2023, 09:09 AM |
| Q1 2023 |
3 |
$128M |
$0 |
-$25M |
-$25M |
APO, COOP, CUROQ
|
13F-HR |
5/15/2023, 09:32 AM |
| Q4 2022 |
4 |
$160M |
+$2.49M |
-$8.87M |
-$6.38M |
APO, COOP, OMF, CUROQ
|
13F-HR |
2/14/2023, 08:59 AM |
| Q3 2022 |
4 |
$142M |
+$23.6M |
-$26.6M |
-$2.97M |
APO, COOP, OMF, CUROQ
|
13F-HR |
11/14/2022, 11:33 AM |
| Q2 2022 |
4 |
$149M |
+$28M |
$0 |
+$28M |
APO, COOP, KKR, CUROQ
|
13F-HR |
8/15/2022, 10:11 AM |
| Q1 2022 |
4 |
$171M |
+$85.8M |
-$97.3M |
-$11.4M |
APO, COOP, CUROQ, KKR
|
13F-HR |
5/12/2022, 09:59 AM |
| Q4 2021 |
6 |
$187M |
+$25M |
$0 |
+$25M |
ATH, CUROQ, COOP, PLNT, BFAM
|
13F-HR |
2/11/2022, 09:11 AM |
| Q3 2021 |
3 |
$150M |
+$866K |
-$5.23M |
-$4.37M |
ATH, COOP, CUROQ
|
13F-HR |
11/12/2021, 04:16 PM |
| Q2 2021 |
3 |
$143M |
+$18.3M |
-$21.2M |
-$2.98M |
ATH, CUROQ, COOP
|
13F-HR |
7/20/2021, 03:16 PM |
| Q1 2021 |
4 |
$124M |
+$22.7M |
-$27.2M |
-$4.47M |
ATH, COOP, CUROQ, PFSI
|
13F-HR |
4/27/2021, 02:59 PM |
| Q4 2020 |
5 |
$114M |
+$13.2M |
-$37M |
-$23.8M |
ATH, COOP, PFSI, SSPK, SSPKW
|
Restatement |
2/17/2021, 04:15 PM |
| Q3 2020 |
3 |
$106M |
+$8.52M |
-$16.6M |
-$8.06M |
COOP, ATH, PFSI
|
13F-HR |
10/28/2020, 06:20 PM |
| Q2 2020 |
5 |
$77.8M |
+$1.33M |
-$33.7M |
-$32.4M |
COOP, ATH, PFSI, PMT, OCN
|
13F-HR |
7/31/2020, 09:21 AM |
| Q1 2020 |
7 |
$80.7M |
+$52.5M |
-$18.4M |
+$34.1M |
COOP, ATH, KKR, RWT, PFSI
|
13F-HR |
5/1/2020, 11:37 AM |
| Q4 2019 |
4 |
$74.9M |
$0 |
$0 |
|
COOP, ATH, FSK, OCN
|
13F-HR |
2/11/2020, 12:40 PM |